This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, C. K.
Right arrow Articles by Hospenthal, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, C. K.
Right arrow Articles by Hospenthal, D. R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2004, p. 4002-4005, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.4002-4005.2004

Determination of Susceptibilities of 26 Leptospira sp. Serovars to 24 Antimicrobial Agents by a Broth Microdilution Technique

Clinton K. Murray and Duane R. Hospenthal*

Infectious Disease Service, Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, Texas

Received 7 April 2004/ Returned for modification 6 June 2004/ Accepted 23 June 2004

The MICs of 24 antimicrobials for 26 Leptospira spp. serovars were determined using a broth microdilution technique. The MICs at which 90% of isolates tested were inhibited (MIC90s) of cefepime, imipenem-cilastatin, erythromycin, clarithromycin, and telithromycin were all ≤0.01 µg/ml. The MIC90s of amoxicillin, aztreonam, cefdinir, chloramphenicol, and penicillin G were ≥3.13 µg/ml. Many antimicrobials have excellent in vitro activity against Leptospira.


* Corresponding author. Mailing address: Infectious Disease (MCHE-MDI), Brooke Army Medical Center, 3851 Roger Brooke Dr., Fort Sam Houston, TX 78234. Phone: (210) 916-4355. Fax: (210) 916-0388. E-mail: Duane.Hospenthal{at}amedd.army.mil.


Antimicrobial Agents and Chemotherapy, October 2004, p. 4002-4005, Vol. 48, No. 10
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.10.4002-4005.2004




This article has been cited by other articles:

  • Ressner, R. A., Griffith, M. E., Beckius, M. L., Pimentel, G., Miller, R. S., Mende, K., Fraser, S. L., Galloway, R. L., Hospenthal, D. R., Murray, C. K. (2008). Antimicrobial Susceptibilities of Geographically Diverse Clinical Human Isolates of Leptospira. Antimicrob. Agents Chemother. 52: 2750-2754 [Abstract] [Full Text]  
  • Moon, J. E., Rivard, R. G., Griffith, M. E., Ressner, R. A., McCall, S., Reitstetter, R. E., Hospenthal, D. R., Murray, C. K. (2007). Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. J Antimicrob Chemother 59: 148-151 [Abstract] [Full Text]  
  • Moon, J. E., Ellis, M. C., Griffith, M. E., Hawley, J. S., Rivard, R. G., McCall, S., Hospenthal, D. R., Murray, C. K. (2006). Efficacy of Macrolides and Telithromycin against Leptospirosis in a Hamster Model.. Antimicrob. Agents Chemother. 50: 1989-1992 [Abstract] [Full Text]